SZSE Releases
Companies
Releases
Pricing
Home
/
Companies
/
Walvax Biotechnology Co., Ltd.
/
Release
300142
SZSE
Announcement on Adsorbed Tetanus Vaccine Entering Phase III Clinical Trials
Walvax Biotechnology Co., Ltd.
·
March 6, 2026
Full Translation